[{"edinetCode":"E00931","endDate":"2017\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1898.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":28450000.0,"sharesOwendPercent":0.405,"outstandingShares":null,"numberOfSubsidiary":4.0,"bps":1693.81,"equityRatio":0.756,"cashAndCashEquivalents":35914000000.0,"assets":150905000000.0,"currentAssets":98787000000.0,"fixedAsset":52118000000.0,"tangibleFixedAssets":20043000000.0,"intangibleFixedAssets":494000000.0,"investmentAndOtherAssets":31580000000.0,"liabilities":36589000000.0,"currentLiabilities":27001000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":9587000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":114316000000.0,"capitalStock":107067000000.0,"capital":5174000000.0,"capitalSurplus":4445000000.0,"accumulatedEarnings":99897000000.0,"treasuryStock":-2450000000.0,"valuationAndConversionAdjustments":7022000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":98781000000.0,"costOfSales":44835000000.0,"grossProfit":53946000000.0,"sgaExpenses":38666000000.0,"salaryAndBenefit":8110000000.0,"depreciationAndSGA":396000000.0,"RDExpenses":14903000000.0,"operatingIncome":15280000000.0,"nonOperatingIncome":1587000000.0,"nonOperatingExpenses":623000000.0,"interestExpense":3000000.0,"ordinaryProfit":16244000000.0,"extraordinaryGain":null,"extraordinaryLoss":766000000.0,"incomeBeforeTax":15477000000.0,"incomeTaxes":3712000000.0,"netIncome":11765000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":11749000000.0,"comprehensiveIncome":13102000000.0,"eps":174.42,"dilutedEps":null,"dividendPerShare":null,"per":32.5,"roe":0.108,"cashFlowFromOperatingActivities":18916000000.0,"depreciationAndCashflowFromOperatingActivities":2648000000.0,"cashFlowFromInvestingActivities":-5750000000.0,"cashFlowFromFinancialActivities":-2193000000.0,"changesInCashAndCashEquivalents":11098000000.0,"列1":"asr","submitDate":"2017\/6\/30","stockCode":4516,"accountingYear":"第154期（自　平成28年４月１日　至　平成29年３月31日）","accountingYearStart":"2016\/4\/1","accountingYearEnd":"2017\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00931","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5174,"settlementDate":"2022\/3\/31","submitterName":"日本新薬株式会社","submitterNameEnglish":"Nippon Shinyaku Co.,Ltd.","submitterNameKana":"ニッポンシンヤクカブシキガイシャ","location":"京都市南区吉祥院西ノ庄門口町１４番地","industory":"医薬品","corporateNumber":2130000000000.0},{"edinetCode":"E00931","endDate":"2018\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1928.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":28089000.0,"sharesOwendPercent":0.417,"outstandingShares":null,"numberOfSubsidiary":4.0,"bps":1862.54,"equityRatio":0.793,"cashAndCashEquivalents":27510000000.0,"assets":158192000000.0,"currentAssets":97953000000.0,"fixedAsset":60238000000.0,"tangibleFixedAssets":21102000000.0,"intangibleFixedAssets":484000000.0,"investmentAndOtherAssets":38652000000.0,"liabilities":32503000000.0,"currentLiabilities":22454000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":10048000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":125689000000.0,"capitalStock":116234000000.0,"capital":5174000000.0,"capitalSurplus":4445000000.0,"accumulatedEarnings":109078000000.0,"treasuryStock":-2464000000.0,"valuationAndConversionAdjustments":9216000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":101448000000.0,"costOfSales":46929000000.0,"grossProfit":54519000000.0,"sgaExpenses":37439000000.0,"salaryAndBenefit":8345000000.0,"depreciationAndSGA":458000000.0,"RDExpenses":13221000000.0,"operatingIncome":17079000000.0,"nonOperatingIncome":1122000000.0,"nonOperatingExpenses":751000000.0,"interestExpense":3000000.0,"ordinaryProfit":17451000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":17451000000.0,"incomeTaxes":4482000000.0,"netIncome":12969000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":12953000000.0,"comprehensiveIncome":15163000000.0,"eps":192.31,"dilutedEps":null,"dividendPerShare":null,"per":37.0,"roe":0.108,"cashFlowFromOperatingActivities":6719000000.0,"depreciationAndCashflowFromOperatingActivities":2773000000.0,"cashFlowFromInvestingActivities":-11342000000.0,"cashFlowFromFinancialActivities":-3787000000.0,"changesInCashAndCashEquivalents":-8404000000.0,"列1":"asr","submitDate":"2018\/6\/29","stockCode":4516,"accountingYear":"第155期（自　平成29年４月１日　至　平成30年３月31日）","accountingYearStart":"2017\/4\/1","accountingYearEnd":"2018\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00931","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5174,"settlementDate":"2022\/3\/31","submitterName":"日本新薬株式会社","submitterNameEnglish":"Nippon Shinyaku Co.,Ltd.","submitterNameKana":"ニッポンシンヤクカブシキガイシャ","location":"京都市南区吉祥院西ノ庄門口町１４番地","industory":"医薬品","corporateNumber":2130000000000.0},{"edinetCode":"E00931","endDate":"2019\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":1951.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":31309000.0,"sharesOwendPercent":0.4648,"outstandingShares":null,"numberOfSubsidiary":4.0,"bps":2003.39,"equityRatio":0.8,"cashAndCashEquivalents":39632000000.0,"assets":168763000000.0,"currentAssets":110720000000.0,"fixedAsset":58042000000.0,"tangibleFixedAssets":20575000000.0,"intangibleFixedAssets":412000000.0,"investmentAndOtherAssets":37054000000.0,"liabilities":33572000000.0,"currentLiabilities":25406000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":8165000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":135190000000.0,"capitalStock":128827000000.0,"capital":5174000000.0,"capitalSurplus":4445000000.0,"accumulatedEarnings":121677000000.0,"treasuryStock":-2469000000.0,"valuationAndConversionAdjustments":6109000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":114716000000.0,"costOfSales":50952000000.0,"grossProfit":63764000000.0,"sgaExpenses":43119000000.0,"salaryAndBenefit":8635000000.0,"depreciationAndSGA":349000000.0,"RDExpenses":16701000000.0,"operatingIncome":20644000000.0,"nonOperatingIncome":1435000000.0,"nonOperatingExpenses":539000000.0,"interestExpense":3000000.0,"ordinaryProfit":21540000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":21540000000.0,"incomeTaxes":5217000000.0,"netIncome":16323000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":16302000000.0,"comprehensiveIncome":13215000000.0,"eps":242.04,"dilutedEps":null,"dividendPerShare":null,"per":33.3,"roe":0.125,"cashFlowFromOperatingActivities":15310000000.0,"depreciationAndCashflowFromOperatingActivities":3418000000.0,"cashFlowFromInvestingActivities":511000000.0,"cashFlowFromFinancialActivities":-3708000000.0,"changesInCashAndCashEquivalents":12122000000.0,"列1":"asr","submitDate":"2019\/6\/28","stockCode":4516,"accountingYear":"第156期（自　2018年４月１日　至　2019年３月31日）","accountingYearStart":"2018\/4\/1","accountingYearEnd":"2019\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00931","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5174,"settlementDate":"2022\/3\/31","submitterName":"日本新薬株式会社","submitterNameEnglish":"Nippon Shinyaku Co.,Ltd.","submitterNameKana":"ニッポンシンヤクカブシキガイシャ","location":"京都市南区吉祥院西ノ庄門口町１４番地","industory":"医薬品","corporateNumber":2130000000000.0},{"edinetCode":"E00931","endDate":"2019\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.805,"cashAndCashEquivalents":null,"assets":168934000000.0,"currentAssets":110657000000.0,"fixedAsset":58276000000.0,"tangibleFixedAssets":20852000000.0,"intangibleFixedAssets":397000000.0,"investmentAndOtherAssets":37026000000.0,"liabilities":32626000000.0,"currentLiabilities":24846000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":7780000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":136307000000.0,"capitalStock":131016000000.0,"capital":5174000000.0,"capitalSurplus":4445000000.0,"accumulatedEarnings":123866000000.0,"treasuryStock":-2469000000.0,"valuationAndConversionAdjustments":5035000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":29391000000.0,"costOfSales":13300000000.0,"grossProfit":16091000000.0,"sgaExpenses":9637000000.0,"salaryAndBenefit":1735000000.0,"depreciationAndSGA":82000000.0,"RDExpenses":2969000000.0,"operatingIncome":6453000000.0,"nonOperatingIncome":455000000.0,"nonOperatingExpenses":323000000.0,"interestExpense":0.0,"ordinaryProfit":6585000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":6585000000.0,"incomeTaxes":1627000000.0,"netIncome":4958000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":4951000000.0,"comprehensiveIncome":3884000000.0,"eps":73.51,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2019\/8\/9","stockCode":4516,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00931","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5174,"settlementDate":"2022\/3\/31","submitterName":"日本新薬株式会社","submitterNameEnglish":"Nippon Shinyaku Co.,Ltd.","submitterNameKana":"ニッポンシンヤクカブシキガイシャ","location":"京都市南区吉祥院西ノ庄門口町１４番地","industory":"医薬品","corporateNumber":2130000000000.0},{"edinetCode":"E00931","endDate":"2019\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":30989000.0,"sharesOwendPercent":0.4601,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.816,"cashAndCashEquivalents":46483000000.0,"assets":171042000000.0,"currentAssets":114444000000.0,"fixedAsset":56597000000.0,"tangibleFixedAssets":20867000000.0,"intangibleFixedAssets":436000000.0,"investmentAndOtherAssets":35293000000.0,"liabilities":31159000000.0,"currentLiabilities":23799000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":7359000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":139883000000.0,"capitalStock":134356000000.0,"capital":5174000000.0,"capitalSurplus":4445000000.0,"accumulatedEarnings":127207000000.0,"treasuryStock":-2470000000.0,"valuationAndConversionAdjustments":5267000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":57387000000.0,"costOfSales":26307000000.0,"grossProfit":31079000000.0,"sgaExpenses":20054000000.0,"salaryAndBenefit":3476000000.0,"depreciationAndSGA":167000000.0,"RDExpenses":6567000000.0,"operatingIncome":11025000000.0,"nonOperatingIncome":767000000.0,"nonOperatingExpenses":521000000.0,"interestExpense":1000000.0,"ordinaryProfit":11271000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":11271000000.0,"incomeTaxes":2968000000.0,"netIncome":8302000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":8291000000.0,"comprehensiveIncome":7461000000.0,"eps":123.11,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":11555000000.0,"depreciationAndCashflowFromOperatingActivities":1694000000.0,"cashFlowFromInvestingActivities":-1860000000.0,"cashFlowFromFinancialActivities":-2763000000.0,"changesInCashAndCashEquivalents":6850000000.0,"列1":"q2r","submitDate":"2019\/11\/8","stockCode":4516,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00931","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5174,"settlementDate":"2022\/3\/31","submitterName":"日本新薬株式会社","submitterNameEnglish":"Nippon Shinyaku Co.,Ltd.","submitterNameKana":"ニッポンシンヤクカブシキガイシャ","location":"京都市南区吉祥院西ノ庄門口町１４番地","industory":"医薬品","corporateNumber":2130000000000.0},{"edinetCode":"E00931","endDate":"2019\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.819,"cashAndCashEquivalents":null,"assets":172719000000.0,"currentAssets":116707000000.0,"fixedAsset":56012000000.0,"tangibleFixedAssets":20743000000.0,"intangibleFixedAssets":475000000.0,"investmentAndOtherAssets":34793000000.0,"liabilities":30914000000.0,"currentLiabilities":23807000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":7106000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":141805000000.0,"capitalStock":135053000000.0,"capital":5174000000.0,"capitalSurplus":4445000000.0,"accumulatedEarnings":127905000000.0,"treasuryStock":-2472000000.0,"valuationAndConversionAdjustments":6488000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":88113000000.0,"costOfSales":40683000000.0,"grossProfit":47430000000.0,"sgaExpenses":31964000000.0,"salaryAndBenefit":7228000000.0,"depreciationAndSGA":262000000.0,"RDExpenses":11011000000.0,"operatingIncome":15466000000.0,"nonOperatingIncome":1433000000.0,"nonOperatingExpenses":621000000.0,"interestExpense":1000000.0,"ordinaryProfit":16277000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":16277000000.0,"incomeTaxes":4374000000.0,"netIncome":11902000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":11886000000.0,"comprehensiveIncome":12281000000.0,"eps":176.47,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2020\/2\/7","stockCode":4516,"accountingYear":null,"accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00931","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5174,"settlementDate":"2022\/3\/31","submitterName":"日本新薬株式会社","submitterNameEnglish":"Nippon Shinyaku Co.,Ltd.","submitterNameKana":"ニッポンシンヤクカブシキガイシャ","location":"京都市南区吉祥院西ノ庄門口町１４番地","industory":"医薬品","corporateNumber":2130000000000.0},{"edinetCode":"E00931","endDate":"2020\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2026.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":31410000.0,"sharesOwendPercent":0.4663,"outstandingShares":null,"numberOfSubsidiary":4.0,"bps":2160.11,"equityRatio":0.831,"cashAndCashEquivalents":44298000000.0,"assets":175017000000.0,"currentAssets":121925000000.0,"fixedAsset":53091000000.0,"tangibleFixedAssets":20944000000.0,"intangibleFixedAssets":546000000.0,"investmentAndOtherAssets":31600000000.0,"liabilities":29256000000.0,"currentLiabilities":24965000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":4290000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":145760000000.0,"capitalStock":140032000000.0,"capital":5174000000.0,"capitalSurplus":4445000000.0,"accumulatedEarnings":132886000000.0,"treasuryStock":-2473000000.0,"valuationAndConversionAdjustments":5458000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":116637000000.0,"costOfSales":53155000000.0,"grossProfit":63481000000.0,"sgaExpenses":41813000000.0,"salaryAndBenefit":9198000000.0,"depreciationAndSGA":352000000.0,"RDExpenses":13994000000.0,"operatingIncome":21668000000.0,"nonOperatingIncome":1599000000.0,"nonOperatingExpenses":824000000.0,"interestExpense":2000000.0,"ordinaryProfit":22442000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":22442000000.0,"incomeTaxes":5553000000.0,"netIncome":16888000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":16866000000.0,"comprehensiveIncome":16237000000.0,"eps":250.42,"dilutedEps":null,"dividendPerShare":null,"per":33.9,"roe":0.12,"cashFlowFromOperatingActivities":12737000000.0,"depreciationAndCashflowFromOperatingActivities":3468000000.0,"cashFlowFromInvestingActivities":-2339000000.0,"cashFlowFromFinancialActivities":-5660000000.0,"changesInCashAndCashEquivalents":4665000000.0,"列1":"asr","submitDate":"2020\/6\/29","stockCode":4516,"accountingYear":"第157期（自　2019年４月１日　至　2020年３月31日）","accountingYearStart":"2019\/4\/1","accountingYearEnd":"2020\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00931","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5174,"settlementDate":"2022\/3\/31","submitterName":"日本新薬株式会社","submitterNameEnglish":"Nippon Shinyaku Co.,Ltd.","submitterNameKana":"ニッポンシンヤクカブシキガイシャ","location":"京都市南区吉祥院西ノ庄門口町１４番地","industory":"医薬品","corporateNumber":2130000000000.0},{"edinetCode":"E00931","endDate":"2020\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.838,"cashAndCashEquivalents":null,"assets":178391000000.0,"currentAssets":123986000000.0,"fixedAsset":54404000000.0,"tangibleFixedAssets":20831000000.0,"intangibleFixedAssets":552000000.0,"investmentAndOtherAssets":33020000000.0,"liabilities":28627000000.0,"currentLiabilities":24696000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":3930000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":149763000000.0,"capitalStock":142991000000.0,"capital":5174000000.0,"capitalSurplus":4445000000.0,"accumulatedEarnings":135844000000.0,"treasuryStock":-2473000000.0,"valuationAndConversionAdjustments":6497000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":29913000000.0,"costOfSales":12818000000.0,"grossProfit":17094000000.0,"sgaExpenses":9571000000.0,"salaryAndBenefit":1913000000.0,"depreciationAndSGA":89000000.0,"RDExpenses":2836000000.0,"operatingIncome":7522000000.0,"nonOperatingIncome":427000000.0,"nonOperatingExpenses":226000000.0,"interestExpense":0.0,"ordinaryProfit":7723000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":7723000000.0,"incomeTaxes":1882000000.0,"netIncome":5841000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":5835000000.0,"comprehensiveIncome":6880000000.0,"eps":86.64,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2020\/8\/13","stockCode":4516,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00931","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5174,"settlementDate":"2022\/3\/31","submitterName":"日本新薬株式会社","submitterNameEnglish":"Nippon Shinyaku Co.,Ltd.","submitterNameKana":"ニッポンシンヤクカブシキガイシャ","location":"京都市南区吉祥院西ノ庄門口町１４番地","industory":"医薬品","corporateNumber":2130000000000.0},{"edinetCode":"E00931","endDate":"2020\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":31334000.0,"sharesOwendPercent":0.4652,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.844,"cashAndCashEquivalents":47494000000.0,"assets":180453000000.0,"currentAssets":125376000000.0,"fixedAsset":55077000000.0,"tangibleFixedAssets":20909000000.0,"intangibleFixedAssets":596000000.0,"investmentAndOtherAssets":33570000000.0,"liabilities":27831000000.0,"currentLiabilities":24333000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":3498000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":152621000000.0,"capitalStock":145208000000.0,"capital":5174000000.0,"capitalSurplus":4445000000.0,"accumulatedEarnings":138063000000.0,"treasuryStock":-2474000000.0,"valuationAndConversionAdjustments":7134000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":57817000000.0,"costOfSales":24994000000.0,"grossProfit":32823000000.0,"sgaExpenses":21682000000.0,"salaryAndBenefit":4132000000.0,"depreciationAndSGA":186000000.0,"RDExpenses":7659000000.0,"operatingIncome":11140000000.0,"nonOperatingIncome":600000000.0,"nonOperatingExpenses":492000000.0,"interestExpense":1000000.0,"ordinaryProfit":11248000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":11248000000.0,"incomeTaxes":3166000000.0,"netIncome":8081000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":8073000000.0,"comprehensiveIncome":9758000000.0,"eps":119.87,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":8127000000.0,"depreciationAndCashflowFromOperatingActivities":1740000000.0,"cashFlowFromInvestingActivities":-2071000000.0,"cashFlowFromFinancialActivities":-2899000000.0,"changesInCashAndCashEquivalents":3196000000.0,"列1":"q2r","submitDate":"2020\/11\/9","stockCode":4516,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00931","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5174,"settlementDate":"2022\/3\/31","submitterName":"日本新薬株式会社","submitterNameEnglish":"Nippon Shinyaku Co.,Ltd.","submitterNameKana":"ニッポンシンヤクカブシキガイシャ","location":"京都市南区吉祥院西ノ庄門口町１４番地","industory":"医薬品","corporateNumber":2130000000000.0},{"edinetCode":"E00931","endDate":"2020\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.858,"cashAndCashEquivalents":null,"assets":181840000000.0,"currentAssets":127719000000.0,"fixedAsset":54120000000.0,"tangibleFixedAssets":20870000000.0,"intangibleFixedAssets":619000000.0,"investmentAndOtherAssets":32631000000.0,"liabilities":25584000000.0,"currentLiabilities":22391000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":3192000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":156256000000.0,"capitalStock":148919000000.0,"capital":5174000000.0,"capitalSurplus":4445000000.0,"accumulatedEarnings":141775000000.0,"treasuryStock":-2475000000.0,"valuationAndConversionAdjustments":7054000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":91837000000.0,"costOfSales":38146000000.0,"grossProfit":53691000000.0,"sgaExpenses":33328000000.0,"salaryAndBenefit":8254000000.0,"depreciationAndSGA":278000000.0,"RDExpenses":11459000000.0,"operatingIncome":20362000000.0,"nonOperatingIncome":1599000000.0,"nonOperatingExpenses":938000000.0,"interestExpense":1000000.0,"ordinaryProfit":21023000000.0,"extraordinaryGain":62000000.0,"extraordinaryLoss":null,"incomeBeforeTax":21086000000.0,"incomeTaxes":5988000000.0,"netIncome":15097000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":15085000000.0,"comprehensiveIncome":16693000000.0,"eps":223.97,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2021\/2\/10","stockCode":4516,"accountingYear":null,"accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00931","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5174,"settlementDate":"2022\/3\/31","submitterName":"日本新薬株式会社","submitterNameEnglish":"Nippon Shinyaku Co.,Ltd.","submitterNameKana":"ニッポンシンヤクカブシキガイシャ","location":"京都市南区吉祥院西ノ庄門口町１４番地","industory":"医薬品","corporateNumber":2130000000000.0},{"edinetCode":"E00931","endDate":"2021\/3\/31","Report abbreviation_x":"asr","context_x":"当期連結時点","numberOfEmployee":2059.0,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":31570000.0,"sharesOwendPercent":0.4687,"outstandingShares":null,"numberOfSubsidiary":4.0,"bps":2409.01,"equityRatio":0.824,"cashAndCashEquivalents":57883000000.0,"assets":197028000000.0,"currentAssets":139090000000.0,"fixedAsset":57937000000.0,"tangibleFixedAssets":21306000000.0,"intangibleFixedAssets":677000000.0,"investmentAndOtherAssets":35954000000.0,"liabilities":34485000000.0,"currentLiabilities":31514000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":2970000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":162543000000.0,"capitalStock":154535000000.0,"capital":5174000000.0,"capitalSurplus":4445000000.0,"accumulatedEarnings":147391000000.0,"treasuryStock":-2476000000.0,"valuationAndConversionAdjustments":7719000000.0,"Report abbreviation_y":"asr","context_y":"当期連結期間","Sales":121885000000.0,"costOfSales":49954000000.0,"grossProfit":71931000000.0,"sgaExpenses":45796000000.0,"salaryAndBenefit":10211000000.0,"depreciationAndSGA":374000000.0,"RDExpenses":16104000000.0,"operatingIncome":26134000000.0,"nonOperatingIncome":1326000000.0,"nonOperatingExpenses":701000000.0,"interestExpense":2000000.0,"ordinaryProfit":26760000000.0,"extraordinaryGain":1998000000.0,"extraordinaryLoss":null,"incomeBeforeTax":28759000000.0,"incomeTaxes":8038000000.0,"netIncome":20721000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":20702000000.0,"comprehensiveIncome":22982000000.0,"eps":307.37,"dilutedEps":null,"dividendPerShare":null,"per":26.8,"roe":0.135,"cashFlowFromOperatingActivities":21388000000.0,"depreciationAndCashflowFromOperatingActivities":3550000000.0,"cashFlowFromInvestingActivities":-1564000000.0,"cashFlowFromFinancialActivities":-6199000000.0,"changesInCashAndCashEquivalents":13584000000.0,"列1":"asr","submitDate":"2021\/6\/30","stockCode":4516,"accountingYear":"第158期（自　2020年４月１日　至　2021年３月31日）","accountingYearStart":"2020\/4\/1","accountingYearEnd":"2021\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00931","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5174,"settlementDate":"2022\/3\/31","submitterName":"日本新薬株式会社","submitterNameEnglish":"Nippon Shinyaku Co.,Ltd.","submitterNameKana":"ニッポンシンヤクカブシキガイシャ","location":"京都市南区吉祥院西ノ庄門口町１４番地","industory":"医薬品","corporateNumber":2130000000000.0},{"edinetCode":"E00931","endDate":"2021\/6\/30","Report abbreviation_x":"q1r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.85,"cashAndCashEquivalents":null,"assets":200114000000.0,"currentAssets":143004000000.0,"fixedAsset":57109000000.0,"tangibleFixedAssets":21569000000.0,"intangibleFixedAssets":711000000.0,"investmentAndOtherAssets":34827000000.0,"liabilities":29648000000.0,"currentLiabilities":26590000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":3058000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":170465000000.0,"capitalStock":163509000000.0,"capital":5174000000.0,"capitalSurplus":4445000000.0,"accumulatedEarnings":156366000000.0,"treasuryStock":-2476000000.0,"valuationAndConversionAdjustments":6661000000.0,"Report abbreviation_y":"q1r","context_y":"当四半期累計期間連結期間","Sales":41157000000.0,"costOfSales":13231000000.0,"grossProfit":27925000000.0,"sgaExpenses":11477000000.0,"salaryAndBenefit":2068000000.0,"depreciationAndSGA":92000000.0,"RDExpenses":3699000000.0,"operatingIncome":16448000000.0,"nonOperatingIncome":369000000.0,"nonOperatingExpenses":220000000.0,"interestExpense":0.0,"ordinaryProfit":16598000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":16598000000.0,"incomeTaxes":4250000000.0,"netIncome":12347000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":12341000000.0,"comprehensiveIncome":11289000000.0,"eps":183.24,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q1r","submitDate":"2021\/8\/12","stockCode":4516,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00931","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5174,"settlementDate":"2022\/3\/31","submitterName":"日本新薬株式会社","submitterNameEnglish":"Nippon Shinyaku Co.,Ltd.","submitterNameKana":"ニッポンシンヤクカブシキガイシャ","location":"京都市南区吉祥院西ノ庄門口町１４番地","industory":"医薬品","corporateNumber":2130000000000.0},{"edinetCode":"E00931","endDate":"2021\/9\/30","Report abbreviation_x":"q2r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":34497000.0,"sharesOwendPercent":0.5121,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.856,"cashAndCashEquivalents":65883000000.0,"assets":204052000000.0,"currentAssets":146788000000.0,"fixedAsset":57264000000.0,"tangibleFixedAssets":21679000000.0,"intangibleFixedAssets":725000000.0,"investmentAndOtherAssets":34860000000.0,"liabilities":29162000000.0,"currentLiabilities":26155000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":3006000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":174890000000.0,"capitalStock":167728000000.0,"capital":5174000000.0,"capitalSurplus":4445000000.0,"accumulatedEarnings":160585000000.0,"treasuryStock":-2476000000.0,"valuationAndConversionAdjustments":6865000000.0,"Report abbreviation_y":"q2r","context_y":"当四半期累計期間連結期間","Sales":71568000000.0,"costOfSales":24589000000.0,"grossProfit":46979000000.0,"sgaExpenses":25474000000.0,"salaryAndBenefit":4099000000.0,"depreciationAndSGA":185000000.0,"RDExpenses":10005000000.0,"operatingIncome":21504000000.0,"nonOperatingIncome":1127000000.0,"nonOperatingExpenses":380000000.0,"interestExpense":0.0,"ordinaryProfit":22250000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":22250000000.0,"incomeTaxes":5682000000.0,"netIncome":16568000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":16561000000.0,"comprehensiveIncome":15714000000.0,"eps":245.89,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":13333000000.0,"depreciationAndCashflowFromOperatingActivities":1453000000.0,"cashFlowFromInvestingActivities":-1954000000.0,"cashFlowFromFinancialActivities":-3365000000.0,"changesInCashAndCashEquivalents":7999000000.0,"列1":"q2r","submitDate":"2021\/11\/12","stockCode":4516,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00931","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5174,"settlementDate":"2022\/3\/31","submitterName":"日本新薬株式会社","submitterNameEnglish":"Nippon Shinyaku Co.,Ltd.","submitterNameKana":"ニッポンシンヤクカブシキガイシャ","location":"京都市南区吉祥院西ノ庄門口町１４番地","industory":"医薬品","corporateNumber":2130000000000.0},{"edinetCode":"E00931","endDate":"2021\/12\/31","Report abbreviation_x":"q3r","context_x":"当四半期会計期間連結時点","numberOfEmployee":null,"averageTemporaryStaff":null,"averageAge":null,"averageYearsOfService":null,"averageAnnualSalary":null,"sharesOwned":null,"sharesOwendPercent":null,"outstandingShares":null,"numberOfSubsidiary":null,"bps":null,"equityRatio":0.864,"cashAndCashEquivalents":null,"assets":204795000000.0,"currentAssets":148535000000.0,"fixedAsset":56259000000.0,"tangibleFixedAssets":22026000000.0,"intangibleFixedAssets":832000000.0,"investmentAndOtherAssets":33400000000.0,"liabilities":27555000000.0,"currentLiabilities":24508000000.0,"shorTermDept":null,"currentPortionOfBonds":null,"currentPortionOfLongTermDebt":null,"fixedLiabilities":3046000000.0,"bonds":null,"convertibleBond":null,"commercialPaper":null,"longTermDebts":null,"netAsset":177240000000.0,"capitalStock":170338000000.0,"capital":5174000000.0,"capitalSurplus":4445000000.0,"accumulatedEarnings":163196000000.0,"treasuryStock":-2477000000.0,"valuationAndConversionAdjustments":6603000000.0,"Report abbreviation_y":"q3r","context_y":"当四半期累計期間連結期間","Sales":106218000000.0,"costOfSales":37851000000.0,"grossProfit":68366000000.0,"sgaExpenses":39045000000.0,"salaryAndBenefit":8199000000.0,"depreciationAndSGA":286000000.0,"RDExpenses":15706000000.0,"operatingIncome":29321000000.0,"nonOperatingIncome":1785000000.0,"nonOperatingExpenses":543000000.0,"interestExpense":0.0,"ordinaryProfit":30563000000.0,"extraordinaryGain":null,"extraordinaryLoss":null,"incomeBeforeTax":30563000000.0,"incomeTaxes":7946000000.0,"netIncome":22616000000.0,"netIncomeAttributableToOwnersOfTheParentCompany":22606000000.0,"comprehensiveIncome":21500000000.0,"eps":335.64,"dilutedEps":null,"dividendPerShare":null,"per":null,"roe":null,"cashFlowFromOperatingActivities":null,"depreciationAndCashflowFromOperatingActivities":null,"cashFlowFromInvestingActivities":null,"cashFlowFromFinancialActivities":null,"changesInCashAndCashEquivalents":null,"列1":"q3r","submitDate":"2022\/2\/14","stockCode":4516,"accountingYear":null,"accountingYearStart":"2021\/4\/1","accountingYearEnd":"2022\/3\/31","accountingStandards":"Japan GAAP","consolidatedAccounting":true,"edinetCode2":"E00931","organizationCategory":"内国法人・組合","listingClassification":"上場","consolidated":"有","capital3":5174,"settlementDate":"2022\/3\/31","submitterName":"日本新薬株式会社","submitterNameEnglish":"Nippon Shinyaku Co.,Ltd.","submitterNameKana":"ニッポンシンヤクカブシキガイシャ","location":"京都市南区吉祥院西ノ庄門口町１４番地","industory":"医薬品","corporateNumber":2130000000000.0}]